Page 390 - Hematology_ Basic Principles and Practice ( PDFDrive )

320.e6 Part IV Disorders of Hematopoietic Cell Development

246. D’Andrea AD, Yoshimura A, Youssoufian H, et al: The cytoplasmic 271. Bassini A, Zauli G, Migliaccio G, et al: Lineage-restricted expres-
region of the erythropoietin receptor contains nonoverlapping positive sion of protein kinase C isoforms in hematopoiesis. Blood 93:1178,
and negative growth-regulatory domains. Mol Cell Biol 11:1980, 1991. 1999.
247. Damen JE, Krystal G: Early events in erythropoietin-induced signaling. 272. Oshevski S, Le Bousse-Kerdiles MC, Clay D, et al: Differential expres-
Exp Hematol 24:1455, 1996. sion of protein kinase C isoform transcripts in human hematopoietic
248. Watowich SS, Yoshimura A, Longmore GD, et al: Homodimerization progenitors undergoing differentiation. Biochem Biophys Res Commun
and constitutive activation of the erythropoietin receptor. Proc Natl 263:603, 1999.
Acad Sci USA 89:2140, 1992. 273. Li Y, Davis KL, Sytkowski AJ: Protein kinase C-epsilon is necessary for
249. Watowich SS, Hilton DJ, Lodish HF: Activation and inhibition of erythropoietin’s up-regulation of c-myc and for factor-dependent DNA
erythropoietin receptor function: role of receptor dimerization. Mol synthesis. Evidence for discrete signals for growth and differentiation. J
Cell Biol 14:3535, 1994. Biol Chem 271:27025, 1996.
250. Liboi E, Carroll M, D’Andrea AD, et al: Erythropoietin receptor signals 274. Myklebust JH, Smeland EB, Josefsen D, et al: Protein kinase C-alpha
both proliferation and erythroid-specific differentiation. Proc Natl Acad isoform is involved in erythropoietin-induced erythroid differentiation
Sci USA 90:11351, 1993. of CD34(+) progenitor cells from human bone marrow. Blood 95:510,
251. Carroll M, Zhu Y, D’Andrea AD: Erythropoietin-induced cellular 2000.
differentiation requires prolongation of the G1 phase of the cell cycle. 275. von Lindern M, Parren-van Amelsvoort M, van Dijk T, et al: Protein
Proc Natl Acad Sci USA 92:2869, 1995. kinase C alpha controls erythropoietin receptor signaling. J Biol Chem
252. Witthuhn BA, Quelle FW, Silvennoinen O, et al: JAK2 associates 275:34719, 2000.
with the erythropoietin receptor and is tyrosine phosphorylated and 276. Di Baldassarre A, Di Rico M, Di Noia A, et al: Protein kinase C alpha
activated following stimulation with erythropoietin. Cell 74:227, 1993. is differentially activated during neonatal and adult erythropoiesis and
253. Neubauer H, Cumano A, Muller M, et al: Jak2 deficiency defines an favors expression of a reporter gene under the control of the (A)gamma
essential developmental checkpoint in definitive hematopoiesis. Cell globin-promoter in cellular models of hemoglobin switching. J Cell
93:397, 1998. Biochem 101:411, 2007.
254. Klingmuller U, Lorenz U, Cantley LC, et al: Specific recruitment of 277. Tilbrook PA, Ingley E, Williams JH, et al: Lyn tyrosine kinase is
SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 essential for erythropoietin-induced differentiation of J2E erythroid
and termination of proliferative signals. Cell 80:729, 1995. cells. EMBO J 16:1610, 1997.
255. Huang LJ, Constantinescu SN, Lodish HF: The N-terminal domain 278. Chin H, Arai A, Wakao H, et al: Lyn physically associates with the
of Janus kinase 2 is required for Golgi processing and cell surface erythropoietin receptor and may play a role in activation of the Stat5
expression of erythropoietin receptor. Mol Cell 8:1327, 2001. pathway. Blood 91:3734, 1998.
256. Damen JE, Mui AL, Puil L, et al: Phosphatidylinositol 3-kinase associ- 279. Boudot C, Dasse E, Lambert E, et al: Involvement of the Src kinase Lyn
ates, via its Src homology 2 domains, with the activated erythropoietin in phospholipase C-gamma 2 phosphorylation and phosphatidylinosi-
receptor. Blood 81:3204, 1993. tol 3-kinase activation in Epo signalling. Biochem Biophys Res Commun
257. Damen JE, Liu L, Cutler RL, et al: Erythropoietin stimulates the 300:437, 2003.
tyrosine phosphorylation of Shc and its association with Grb2 and a 280. Ingley E, McCarthy DJ, Pore JR, et al: Lyn deficiency reduces GATA-1,
145-Kd tyrosine phosphorylated protein. Blood 82:2296, 1993. EKLF and STAT5, and induces extramedullary stress erythropoiesis.
258. Barber DL, Corless CN, Xia K, et al: Erythropoietin activates Raf1 Oncogene 24:336, 2005.
by an Shc-independent pathway in CTLL-EPO-R cells. Blood 89:55, 281. Samuels AL, Klinken SP, Ingley E: Liar, a novel Lyn-binding nuclear/
1997. cytoplasmic shuttling protein that influences erythropoietin-induced
259. Damen JE, Wakao H, Miyajima A, et al: Tyrosine 343 in the eryth- differentiation. Blood 113:3845, 2009.
ropoietin receptor positively regulates erythropoietin-induced cell 282. Kosmider O, Buet D, Gallais I, et al: Erythropoietin down-regulates
proliferation and Stat5 activation. EMBO J 14:5557, 1995. stem cell factor receptor (Kit) expression in the leukemic proerythro-
260. Klingmuller U, Bergelson S, Hsiao JG, et al: Multiple tyrosine residues blast: role of Lyn kinase. PLoS ONE 4:e5721, 2009.
in the cytosolic domain of the erythropoietin receptor promote activa- 283. De Franceschi L, Tomelleri C, Matte A, et al: Erythrocyte membrane
tion of STAT5. Proc Natl Acad Sci USA 93:8324, 1996. changes of chorea-acanthocytosis are the result of altered Lyn kinase
261. He TC, Jiang N, Zhuang H, et al: Erythropoietin-induced recruitment activity. Blood 118:5652, 2011.
of Shc via a receptor phosphotyrosine-independent, Jak2-associated 284. Sui X, Krantz SB, You M, et al: Synergistic activation of MAP kinase
pathway. J Biol Chem 270:11055, 1995. (ERK1/2) by erythropoietin and stem cell factor is essential for
262. Xia K, Mukhopadhyay NK, Inhorn RC, et al: The cytokine-activated expanded erythropoiesis. Blood 92:1142, 1998.
tyrosine kinase JAK2 activates Raf-1 in a p21ras-dependent manner. 285. Agosti V, Karur V, Sathyanarayana P, et al: A KIT juxtamembrane
Proc Natl Acad Sci USA 93:11681, 1996. PY567 -directed pathway provides nonredundant signals for erythroid
263. Gobert S, Chretien S, Gouilleux F, et al: Identification of tyrosine progenitor cell development and stress erythropoiesis. Exp Hematol
residues within the intracellular domain of the erythropoietin receptor 37:159, 2009.
crucial for STAT5 activation. EMBO J 15:2434, 1996. 286. Racke FK, Lewandowska K, Goueli S, et al: Sustained activation of the
264. Ihle JN, Witthuhn BA, Quelle FW, et al: Signaling by the cytokine extracellular signal-regulated kinase/mitogen-activated protein kinase
receptor superfamily: JAKs and STATs. Trends Biochem Sci 19:222, pathway is required for megakaryocytic differentiation of K562 cells. J
1994. Biol Chem 272:23366, 1997.
265. Zhu Y, Carroll M, Papa FR, et al: DUB-1, a deubiquitinating enzyme 287. Lee SJ, Yoon JH, Song KS: Chrysin inhibited stem cell factor (SCF)/c-
with growth-suppressing activity. Proc Natl Acad Sci USA 93:3275, Kit complex-induced cell proliferation in human myeloid leukemia
1996. cells. Biochem Pharmacol 74:215, 2007.
266. Barber DL, Mason JM, Fukazawa T, et al: Erythropoietin and 288. Han L, Wierenga AT, Rozenveld-Geugien M, et al: Single-cell STAT5
interleukin-3 activate tyrosine phosphorylation of CBL and association signal transduction profiling in normal and leukemic stem and pro-
with CRK adaptor proteins. Blood 89:3166, 1997. genitor cell populations reveals highly distinct cytokine responses. PLoS
267. Rhee SG: Regulation of phosphoinositide-specific phospholipase C. ONE 4:e7989, 2009.
Annu Rev Biochem 70:281, 2001. 289. Hong L, Ramdas B, Chen J, et al: KIT associated intracellular tyro-
268. Irvine RF: Nuclear lipid signalling. Nat Rev Mol Cell Biol 4:349, 2003. sines play an essential role in EpoR co-signaling. Cell Signal 20:1513,
269. van Dijk TB, van Den Akker E, Amelsvoort MP, et al: Stem cell factor 2008.
induces phosphatidylinositol 3’-kinase-dependent Lyn/Tec/Dok-1 290. Darnell JE, Jr, Kerr IM, Stark GR: Jak-STAT pathways and transcrip-
complex formation in hematopoietic cells. Blood 96:3406, 2000. tional activation in response to IFNs and other extracellular signaling
270. Hofmann J: The potential for isoenzyme-selective modulation of proteins. Science 264:1415, 1994.
protein kinase C. FASEB J 11:649, 1997. 291. Ihle JN: Cytokine receptor signalling. Nature 377:591, 1995.